# Impact of Chronic Renal Failure on Plasma Exposure of Kinase Inhibitors in Patients Treated for Metastatic Kidney Cancer

> **NCT04823923** · NA · RECRUITING · sponsor: **Institut du Cancer de Montpellier - Val d'Aurelle** · enrollment: 60 (estimated)

## Conditions studied

- Kidney Neoplasm

## Interventions

- **OTHER:** blood sampling for ITK dosage

## Key facts

- **NCT ID:** NCT04823923
- **Lead sponsor:** Institut du Cancer de Montpellier - Val d'Aurelle
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-12-06
- **Primary completion:** 2026-01
- **Final completion:** 2026-03
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2025-02-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04823923

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04823923, "Impact of Chronic Renal Failure on Plasma Exposure of Kinase Inhibitors in Patients Treated for Metastatic Kidney Cancer". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04823923. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*